PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
48.17
+2.90 (6.41%)
At close: Aug 13, 2025, 4:00 PM
47.51
-0.66 (-1.37%)
Pre-market: Aug 14, 2025, 8:53 AM EDT
PTC Therapeutics Employees
PTC Therapeutics had 939 employees as of December 31, 2024. The number of employees decreased by 116 or -11.00% compared to the previous year.
Employees
939
Change (1Y)
-116
Growth (1Y)
-11.00%
Revenue / Employee
$1,879,584
Profits / Employee
$670,046
Market Cap
3.83B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PTCT News
- 5 days ago - PTC Therapeutics, Inc. (PTCT) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results - PRNewsWire
- 15 days ago - Sephience Gets FDA Approval, Now A Key Revenue Driver For PTC Therapeutics - Benzinga
- 15 days ago - These Analysts Increase Their Forecasts On PTC Therapeutics - Benzinga
- 16 days ago - US FDA approves PTC Therapeutics' metabolic disorder drug - Reuters
- 16 days ago - PTC Therapeutics Announces FDA Approval of Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU) - PRNewsWire
- 23 days ago - PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2025 Financial Results - PRNewsWire
- 7 weeks ago - PTCT Investors Have Opportunity to Join PTC Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - PRNewsWire